Breaking News Instant updates and real-time market news.

AKBA

Akebia

$8.75 /

-0.25 (-2.78%)

05:13
02/18/20
02/18
05:13
02/18/20
05:13

Piper 'increasingly confident' after traveling with Akebia management

Piper Sandler analyst Christopher Raymond says Akebia Therapeutics remains a favorite small cap pick, especially after hosting investor meetings last week with CEO John Butler. After traveling with management, the analyst is "increasingly confident" in the stock's near-term upside potential from the vadadustat's Phase data. He sees numerous events playing out this year that will highlight Akebia "as an undervalued story." Raymond keeps an Overweight rating on the shares with a $15 price target.

AKBA Akebia
$8.75 /

-0.25 (-2.78%)

11/12/19 Piper Sandler
Piper cuts Akebia target to $15 from $22, still recommends buying
10/16/19 H.C. Wainwright
Akebia lawsuit against CMS right course of action, says H.C. Wainwright
08/08/19 Piper Sandler
Akebia's Auryxia 'a nice little growth story,' says Piper Jaffray
07/24/19 H.C. Wainwright
Akebia shares at 'excellent entry point,' says H.C. Wainwright

TODAY'S FREE FLY STORIES

Recommendations
Home Depot price target lowered to $215 from $255 at Credit Suisse » 07:08
04/01/20
04/01
07:08
04/01/20
07:08
HD

Home Depot

$186.78 /

-9.17 (-4.68%)

Credit Suisse analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
Castle Biosciences announces publication of analysis of DecisionDx-Melanoma test » 07:07
04/01/20
04/01
07:07
04/01/20
07:07
CSTL

Castle Biosciences

$29.71 /

+0.85 (+2.95%)

Castle Biosciences…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Recommendations
Lowe's price target lowered to $106 from $131 at Credit Suisse » 07:07
04/01/20
04/01
07:07
04/01/20
07:07
LOW

Lowe's

$86.21 /

-2.52 (-2.84%)

Credit Suisse analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
Plus Therapeutics appoints Gregory Stein as head of clinical development » 07:07
04/01/20
04/01
07:07
04/01/20
07:07
PSTV

Plus Therapeutics

$1.86 /

-0.38 (-16.96%)

Plus Therapeutics…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

Upgrade
El Pollo Loco upgraded to Buy from Hold at SunTrust » 07:07
04/01/20
04/01
07:07
04/01/20
07:07
DENN

Denny's

$7.68 /

-0.17 (-2.17%)

, LOCO

El Pollo Loco

$8.46 /

+0.46 (+5.75%)

, PLAY

Dave & Buster's

$13.06 /

+0.67 (+5.41%)

, SHAK

Shake Shack

$37.70 /

-0.11 (-0.29%)

SunTrust analyst Jake…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
Concert Pharmaceuticals announces plans for CTP-543 phase 3 trials » 07:07
04/01/20
04/01
07:07
04/01/20
07:07
CNCE

Concert Pharmaceuticals

$8.80 /

-0.29 (-3.19%)

Concert Pharmaceuticals…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
Hexindai to delay earnings release for 1H20 » 07:05
04/01/20
04/01
07:05
04/01/20
07:05
HX

Hexindai

$0.42 /

+0.025 (+6.41%)

Hexindai announced that…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

Hot Stocks
Guardion Health Sciences receives initial order for immuno-supportive formula » 07:05
04/01/20
04/01
07:05
04/01/20
07:05
GHSI

Guardion Health Sciences

$0.45 /

+0.0316 (+7.53%)

Guardion Health Sciences…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

Hot Stocks
Red Robin withdraws FY20, long-term guidance due to COVID-19 » 07:05
04/01/20
04/01
07:05
04/01/20
07:05
RRGB

Red Robin

$8.50 /

+0.11 (+1.31%)

Red Robin Gourmet Burgers…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Downgrade
Zoomlion downgraded to Neutral from Buy at Nomura Instinet » 07:05
04/01/20
04/01
07:05
04/01/20
07:05
ZLIOF

Zoomlion

$0.00 /

+ (+0.00%)

Nomura Instinet analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

Hot Stocks
Despegar.com reports COVID-19 mitigation measures » 07:05
04/01/20
04/01
07:05
04/01/20
07:05
DESP

Despegar.com

$5.65 /

+0.08 (+1.44%)

Despegar.com provided a…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Upgrade
Incyte upgraded to Overweight on underappreciated pipeline at Morgan Stanley » 07:05
04/01/20
04/01
07:05
04/01/20
07:05
INCY

Incyte

$73.13 /

+0.96 (+1.33%)

As previously reported,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

General news
FX Update: The dollar and yen have outperformed » 07:05
04/01/20
04/01
07:05
04/01/20
07:05

FX Update: The dollar and…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

Hot Stocks
Centene announces comprehensive support for Safety Net providers » 07:04
04/01/20
04/01
07:04
04/01/20
07:04
CNC

Centene

$59.29 /

+1.61 (+2.79%)

Centene said, "The…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
Flexion reconfirms at least 10 months of finished goods available in the U.S. » 07:04
04/01/20
04/01
07:04
04/01/20
07:04
FLXN

Flexion

$7.84 /

-0.37 (-4.51%)

The company said,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
Flexion announces temporary suspension of clinical trials » 07:03
04/01/20
04/01
07:03
04/01/20
07:03
FLXN

Flexion

$7.84 /

-0.37 (-4.51%)

Flexion is temporarily…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Recommendations
New Residential dividend cut should be viewed positively, says Nomura Instinet » 07:03
04/01/20
04/01
07:03
04/01/20
07:03
NRZ

New Residential

$5.02 /

-0.95 (-15.91%)

Nomura Instinet analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
Centene to cover cost of COVID-19 treatments for Medicare, Medicaid, Marketplace » 07:02
04/01/20
04/01
07:02
04/01/20
07:02
CNC

Centene

$59.29 /

+1.61 (+2.79%)

Centene announced a…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Earnings
Flexion withdraws 2020 revenue guidance » 07:02
04/01/20
04/01
07:02
04/01/20
07:02
FLXN

Flexion

$7.84 /

-0.37 (-4.51%)

The company said,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

General news
MBA Mortgage Applications Composite Index data reported » 07:02
04/01/20
04/01
07:02
04/01/20
07:02

Week of 3/27 MBA Mortgage…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

Hot Stocks
Flexion announces ZILRETTA license agreement in Greater China » 07:02
04/01/20
04/01
07:02
04/01/20
07:02
FLXN

Flexion

$7.84 /

-0.37 (-4.51%)

Flexion Therapeutics…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Recommendations
Masonite price target lowered to $57 from $85 at Nomura Instinet » 07:00
04/01/20
04/01
07:00
04/01/20
07:00
DOOR

Masonite

$47.38 /

-0.59 (-1.23%)

Nomura Instinet analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Recommendations
Lowe's price target raised to $120 from $100 at Nomura Instinet » 06:59
04/01/20
04/01
06:59
04/01/20
06:59
LOW

Lowe's

$86.21 /

-2.52 (-2.84%)

Nomura Instinet analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Upgrade
D.R. Horton upgraded to Outperform after 'overdone' pullback at Wedbush » 06:59
04/01/20
04/01
06:59
04/01/20
06:59
DHI

D.R. Horton

$34.00 /

-2.91 (-7.88%)

As previously reported,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Recommendations
Home Depot price target raised to $215 from $204 at Nomura Instinet » 06:58
04/01/20
04/01
06:58
04/01/20
06:58
HD

Home Depot

$186.78 /

-9.17 (-4.68%)

Nomura Instinet analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.